betiatide

Action and Spectrum

Actions and Spectrum: 

Betiatida plays a part as a compact molecule radiopharmaceutical utilized in renal diagnosis. It is frequently linked to its alternative form, Technetium TC 99M Mertiatide, which serves as a radiographic linking substance for intravenous delivery to identify renal irregularities, deficiencies, urinary tract problems, and calculi in both grown-ups and pediatric patients. 

Drug Interaction

Adverse Reaction

Frequency not defined 

Urticarial rash 

Hypertension 

Swelling of eyelids and coughing 

Itching 

Nausea 

tachycardia  

Vomiting 

Black Box Warning

Black Box Warning: 

None 

Contraindication / Caution

Contraindication/Caution: 

Contraindication 

N/A 

Caution 

N/A 

Pregnancy / Lactation

Pregnancy consideration:  

US FDA pregnancy category: Not assigned 

Lactation:   

Excreted into human milk: Yes. 

Pregnancy category: 

• Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester. 
• Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women. 
• Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.    
• Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.    
• Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.    
• Category N: There is no data available for the drug under this category. 

Pharmacology

Pharmacology: 

The pharmacology of betiatide, also known as Betiatida, involves its role as a small molecule radiopharmaceutical with applications in renal diagnosis. It is commonly associated with its variant, Technetium TC 99M Mertiatide, which is used as a radiologic conjugating agent for intravenous administration in diagnosing renal abnormalities, failures, urinary tract issues, and calculi in both adults and pediatric patients. This compound facilitates the visualization of renal function. It is primarily employed for its diagnostic properties in the field of renal imaging. 

Pharmacodynamics: 

Mechanism of action: 

N/A 

Pharmacokinetics: 

N/A 

Adminstartion

Administration: 

N/A 

Patient Information Leaflet

Patient information leaflet 

Generic Name: betiatide 

Why do we use betiatide? 

betiatide, is a substance with various applications and characteristics.  

betiatide is categorized as a Small Molecule and falls under both Approved and Experimental groups in drug classification. It has an average molecular weight of 367.38 and a monoisotopic weight of 367.08, with a chemical formula of C15H17N3O6SS. 

betiatide may have applications in medical imaging, congenital and acquired renal abnormalities, urinary tract obstruction. One of its variants, known as TechneScan MAG3, has been used for renal diagnosis in adults and children aged 30 days and older.

This indicates that it might be employed as a radiolabeled injection for imaging purposes, providing insights into renal function, angiograms, and renogram curves. Precautions are recommended when handling radiolabeled injections to ensure safety. It’s important to note that this usage information is specific to TechneScan MAG3, which contains betiatide. 

Moreover, limited data suggest that betiatide (TechneScan MAG3) may be used during pregnancy if the benefits outweigh the fetal risks. While no formal pregnancy category is assigned, available data indicate minimal anticipated radiation exposure to fetuses when used below-specified doses.